Nippon Chemiphar Co., Ltd.

Nippon Chemiphar Co., Ltd. manufactures, sells, imports, and exports ethical pharmaceuticals and diagnostic agents in Japan and internationally. Its diagnostic products include IgE NC, a kit that measures total IgE levels, 57 individual allergen reagents, and DP3000 for allergen-specific IgE measurements. The company is developing several drug candidates: NC-2400 (PPAR-delta agonist, Phase 1), NC-2500 (XOR inhibitor for hyperuricemia/gout, Phase 1), NC-2600 (P2X4 receptor antagonist for neuropathic pain, Phase 1), NC-2700 (URAT1 inhibitor for hyperuricemia/gout, preclinical), NC-2800 (delta opioid receptor agonist for depression/anxiety, Phase 1), DFP-17729 (cancer microenvironment improving agent for pancreatic cancer, Phase 2), and DE-P-14323 (anti-cancer agent for non-small cell lung cancer, Phase 2). It is also developing Soleton, an analgesic and anti-inflammatory drug, and Calvan, a blocker for Huntington's disease in Phase 2. Additionally, it offers quasi-drugs, nutrients, health foods, cosmetics, and creams. Formerly Hitachi Chemical Co., Ltd., it changed its name to Nippon Chemiphar Co., Ltd. in 1970, was incorporated in 1950, and is headquartered in Tokyo, Japan.